http://www.farminglife.com/news/farming-news/the-disease-control-challenge-1-7548469
http://www.dailypolitical.com/2016/08/28/merck-co-mrk-position-held-by-old-point-trust-financial-services-n-a/
http://www.webbreakingnews.com/2016/08/28/merck-co-mrk-stake-lowered-by-gillespie-robinson-grimm-inc/
http://www.dailypolitical.com/2016/08/28/traders-sell-merck-co-mrk-on-strength-mrk-2/
http://www.naturalnews.com/055115_autism_vaccine_link_CDC_Dr_William_Thompson.html
http://www.foxbusiness.com/features/2016/08/29/how-mylan-ceo-bresch-played-system.html
http://www.investopedia.com/news/zika-virus-vaccine-overturns-pharma-industry-playbook-gsk-sny-ion/
http://www.zawya.com/story/BlackRock_withheld_support_from_two_key_Exxon_directors-TR20160829nL1N1AX152X2/
http://www.reuters.com/article/us-exxon-directors-blackrock-idUSKCN11417F
http://www.moneycontrol.com/news/stocks-views/see-nuvaring-opportunity-for-dr-reddysq4fy18-credit-suisse_7359961.html
http://www.investopedia.com/news/mylan-launch-cheaper-generic-epipen-myl/
http://247wallst.com/healthcare-business/2016/08/29/why-astrazeneca-could-gain-another-15-despite-market-headwinds/
http://www.finanznachrichten.de/nachrichten-2016-08/38429623-global-cathepsin-k-cathepsin-o-or-cathepsin-x-or-ec-3-4-22-38-therapeutics-pipeline-review-2016-research-and-markets-004.htm
http://www.snopes.com/2016/08/29/mylan-to-offer-generic-epipen/

http://www.xconomy.com/boston/2016/08/29/filing-moderna-blowing-past-record-450m-round-with-new-600m-raise/
http://www.eurekalert.org/pub_releases/2016-08/esoc-bo082916.php
http://www.prnewswire.com/news-releases/biolinerx-to-present-at-the-18th-annual-rodman--renshaw-global-investment-conference-in-new-york-591585301.html
http://www.emailwire.com/release/266445-Global-Market-Survey-Endocrinology-Drugindustry-Report-2016.html
http://lancasteronline.com/opinion/columnists/green-party-candidate-jill-stein-is-just-what-the-doctor/article_76fc7f84-6adb-11e6-8bb2-a70f19a1e996.html

http://www.4-traders.com//news/Global-Histone-Deacetylase-3-SMAP45-or-EC-3-5-1-98-Therapeutics-Pipeline-Review-H1-2016-Researc--22971653/
http://www.4-traders.com//news/Global-HIV-1-Integrase-EC-2-7-7-Pipeline-Review-2016-Research-and-Markets--22971681/

http://www.4-traders.com//news/Peripheral-Nerve-Sheath-Tumor-Neurofibrosarcoma-Market-Pipeline-Review-Report-H1-2016-Research--22971309/

